Table 1 Demographic characteristics of the study groups
From: Altered infective competence of the human gut microbiome in COVID-19
|  | COVID-19 (N = 61) | Controls (N = 57) | P value |
|---|---|---|---|
Age | 43.85 ± 11.92 | 42.12 ± 3.32 | 0.297 |
Sex | |||
 Female | 22 (36.07%) | 22 (38.6%) | 0.776 |
 Male | 39 (63.93%) | 35 (61.4%) | |
COVID-19 severity | |||
 Asymptomatic | 4 (6.56%) | N/A | N/A |
 Mild | 45 (73.77%) | ||
 Moderate | 12 (19.67%) | ||
Hospitalization status | |||
 Hospitalized | 1 (1.64%) | N/A | N/A |
 Not hospitalized | 60 (98.36%) | ||
COVID-19 symptoms | |||
 Fever | 35 (57.38%) | N/A | N/A |
 Runny nose | 11 (18.03%) | ||
 Sore throat | 22 (36.06%) | ||
 Smell and/or taste loss | 32 (52.46%) | ||
 Fatigue | 40 (65.57%) | ||
 Headache | 40 (65.57%) | ||
 Cough | 33 (54.1%) | ||
 Shortness of breath | 12 (19.67) | ||
 Diarrhea | 15 (24.59%) | ||
 Abdominal pain | 1 (1.64%) | ||
 Chest pain | 9 (14.75%) | ||
 Ear pain | 5 (8.2%) | ||
 Joint pain | 6 (9.84) | ||
 Muscle pain | 30 (49.18%) | ||
 Vomiting/nausea/vertigo | 7 (11.47%) | ||